Clinical Trial Update: Efficacy of Dihydroartemisinin for Treating PCOS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dihydroartemisinin for polycystic ovary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Dihydroartemisinin (dihydroartemisinin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Polycystic Ovary Syndrome | Phase 2 | Status: COMPLETED